Ee Von Woon

Ee Von Woon

Auto-generated profile, based on publicly available information

Ee Von Woon

Department of Metabolism, Digestion and Reproduction, Institute of Developmental Reproductive and Developmental Biology, Imperial College London, Chelsea and Westminster Hospital Campus

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 March 2022 in Human Reproduction Update
Verified
Journal Article
Open access
PDF file
EWEe Von Woon
Ee Von Woon
OGOrene Greer
Orene Greer
Nishel Mohan ShahNishel Mohan Shah
Nishel Mohan Shah
DNDimitrios Nikolaou
Dimitrios Nikolaou
MJMark R Johnson
Mark R Johnson
Victoria MaleVictoria Male
Victoria Male
Uterine natural killer cells (uNK) are the most abundant lymphocytes found in the decidua during implantation and in first trimester pregnancy. They are important for early placental development, especially trophoblast invasion and transformation of the spiral arteries. However, inappropriate uNK function has been implicated in reproductive failure, such as recurrent miscarriage (RM) or recurrent implantation failure (RIF). Previous studies have mainly focussed on peripheral NK cells (pNK), despite the well-documented differences in pNK and uNK phenotype and function. In recent years, there has been an explosion of studies conducted on uNK, providing a more suitable representation of the immune environment at the maternal–foetal interface. Here, we summarize the evidence from studies published on uNK in women with RM/RIF compared with controls. The objectives of this systematic review and meta-analysis are to evaluate: differences in uNK level in women with RM/RIF compared with controls; pregnancy outcome in women with RM/RIF stratified by high and normal uNK levels; correlation between uNK and pNK in women with RM/RIF; and differences in uNK activity in women with RM/RIF compared with controls. MEDLINE, EMBASE, Web of Science and Cochrane Trials Registry were searched from inception up to December 2020 and studies were selected in accordance with PRISMA guidelines. Meta-analyses were performed for uNK level, pregnancy outcome and uNK/pNK correlation. Narrative synthesis was conducted for uNK activity. Risk of bias was assessed by ROBINS-I and publication bias by Egger’s test. Our initial search yielded 4636 articles, of which 60 articles were included in our systematic review. Meta-analysis of CD56+ uNK level in women with RM compared with controls showed significantly higher levels in women with RM in subgroup analysis of endometrial samples (standardized mean difference (SMD) 0.49, CI 0.08, 0.90; P = 0.02; I2 88%; 1100 women). Meta-analysis of CD56+ uNK level in endometrium of women with RIF compared with controls showed significantly higher levels in women with RIF (SMD 0.49, CI 0.01, 0.98; P = 0.046; I2 84%; 604 women). There was no difference in pregnancy outcome in women with RM/RIF stratified by uNK level, and no significant correlation between pNK and uNK levels in women with RM/RIF. There was wide variation in studies conducted on uNK activity, which can be broadly divided into regulation and receptors, uNK cytotoxicity, cytokine secretion and effect of uNK on angiogenesis. These studies were largely equivocal in their results on cytokine secretion, but most studies found lower expression of inhibitory receptors and increased expression of angiogenic factors in women with RM. The observation of significantly increased uNK level in endometrium of women with RM and RIF may point to an underlying disturbance of the immune milieu culminating in implantation and/or placentation failure. Further research is warranted to elucidate the underlying pathophysiology. The evidence for measuring pNK as an indicator of uNK behaviour is sparse, and of limited clinical use. Measurement of uNK level/activity may be more useful as a diagnostic tool, however, a standardized reference range must be established before this can be of clinical use.

1 November 2020 in Journal of Reproductive Immunology
Verified
Journal Article
Closed access
EWEe Von Woon
Ee Von Woon
ADAndrea Day
Andrea Day
TBTimothy Bracewell-Milnes
Timothy Bracewell-Milnes
Victoria MaleVictoria Male
Victoria Male
MJMark Johnson
Mark Johnson

13 January 2023 in Frontiers in Immunology
Verified
Journal Article
Open access
EWEe Von Woon
Ee Von Woon
DNDimitrios Nikolaou
Dimitrios Nikolaou
KMKate MacLaran
Kate MacLaran
JNJulian Norman-Taylor
Julian Norman-Taylor
PBPriya Bhagwat
Priya Bhagwat
VMVictoria Male
Victoria Male
A significant proportion of recurrent miscarriage, recurrent implantation failure and infertility are unexplained, and these conditions have been proposed to have an etiology of immunological dysfunction at the maternal-fetal interface. Uterine Natural Killer cells (uNK) comprise three subsets and are the most numerous immune cells found in the uterine mucosa at the time of implantation. They are thought to play an important role in successful pregnancy by regulation of extravillous trophoblast (EVT) invasion and spiral artery remodelling. Here, we examine the frequency, phenotype and function of uNK1-3 from the uterine mucosa of 16 women with unexplained reproductive failure compared to 11 controls with no reproductive problems, during the window of implantation. We report that KIR2DL1/S1 and LILRB1 expression is lower in the reproductive failure group for both uNK (total uNK, uNK 2 and 3) and pNK. We also show that degranulation activity is significantly reduced in total uNK, and that TNF-α production is lower in all uNK subsets in the reproductive failure group. Taken together, our findings suggest that reproductive failure is associated with global reduction in expression of uNK receptors important for interaction with HLA-C and HLA-G on EVT during early pregnancy, leading to reduced uNK activation. This is the first study to examine uNK subsets during the window of implantation in women with reproductive failure and will serve as a platform to focus on particular aspects of phenotype and function of uNK subsets in future studies. Further understanding of uNK dysregulation is important to establish potential diagnostic and therapeutic targets in the population of women with unexplained reproductive failure.

20 January 2025 in Discovery Immunology
Verified
Journal Article
Open access
ACAntonia O Cuff
Antonia O Cuff
EWEe Von Woon
Ee Von Woon
TBThomas Bainton
Thomas Bainton
BBBrendan Browne
Brendan Browne
PKPhoebe M Kirkwood
Phoebe M Kirkwood
Victoria MaleVictoria Male
Victoria Male
Background: Innate lymphoid cells (ILCs) are prominent in the human uterine mucosa and play physiological roles in pregnancy. ILC3 are the second-most common ILC subset in the uterine mucosa, but their role remains unclear. Methods: Here we define two subsets of lineage-negative CD56+ CD117+ CRTH2-uterine ILC3, distinguished by their expression of CD127. Results: The CD127− subset is most numerous and active during menstruation and immediately after parturition, suggesting a role in the repair of the uterine mucosa (called endometrium outside of pregnancy); the CD127+ subset is most numerous and active immediately after menstruation, as the endometrium regenerates. In healthy endometrium, ILC3 are spatially associated with glandular epithelial and endothelial cells, which both express receptors for the ILC3-derived cytokines, IL-22 and IL-8. In the eutopic endometrium of people with endometriosis, ILC3 are located further from glandular epithelial and endothelial cells suggesting that these cells may be less exposed to ILC3 products, potentially with negative consequences for endometrial regeneration. Conclusion: Our findings highlight the dynamic nature of ILC3 in the uterine mucosa and suggest their primary role is in repair and regeneration. An improved understanding of uterine ILC3 will inform future research on endometrial health and disease.

16 January 2025 in The Obstetrician & Gynaecologist
Verified
Journal Article
Open access
OGOrene Greer
Orene Greer
ZSZainab Saeed
Zainab Saeed
EWEe Von Woon
Ee Von Woon
NSNatasha Singh
Natasha Singh
MJMark Johnson
Mark Johnson
Nishel Mohan ShahNishel Mohan Shah
Nishel Mohan Shah
Key content: COVID‐19 is known to be associated with significant morbidity for pregnant women and their babies. This susceptibility to adverse clinical outcomes may be associated with the unique physiological characteristics of the pregnant host. Public health measures recommended for the management and prevention of critical COVID‐19 in pregnancy and lactation evolved during the 2020 pandemic; some decisions were controversial. We highlight lessons learnt and considerations for future pandemic preparedness. Learning objectives: To outline the pathology of COVID‐19 in pregnancy, including placental involvement. To summarise current evidence‐based management and signpost to resources updates. To discuss the role of vaccines to reduce morbidity and mortality for existing and novel SARS‐CoV‐2 viral strains. Ethical issues: Sustained international collaborative strategies are crucial to ensure global equity for access to treatment and vaccines for communicable diseases.

30 March 2022 in medRxiv
Verified
Preprint
Open access
PDF file
EWEe Von Woon
Ee Von Woon
Victoria MaleVictoria Male
Victoria Male
COVID-19 vaccination protects against the potentially serious consequences of SARS-CoV2 infection, but some people have been hesitant to receive the vaccine because of reports that it could affect menstrual bleeding. To determine whether this occurs, we prospectively recruited a cohort of 79 individuals, each of whom recorded details of at least three consecutive menstrual cycles, during which time they each received at least one dose of COVID-19 vaccine. We find that either dose of the COVID-19 vaccine is associated with a delay to the subsequent period in spontaneously cycling participants (2.3 days after dose 1; 1.3 days after dose 2) but this change rapidly reverses. No change to timing was detected in those on hormonal contraception. We detected no change in menstrual flow associated with either dose of the vaccine, in either spontaneously cycling participants or those on hormonal contraception. We detected no association between menstrual changes and other commonly-reported side effects of vaccination, such as sore arm, fever and fatigue.